Floatz logo

Loperamide

Neratinib

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Neratinib cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Loperamide is also rated in:

diarrheal diseaseDormant
BB
Indicative ·
66 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
B
Indicative ·
62 / 100
View asset →
breast cancerDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →